These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22813903)

  • 21. Does infection by the hepatitis C virus decrease the response of immunization against the hepatitis B virus in individuals undergoing dialysis?
    Ferreira TMB; Guimarães TGS; Fontenele AMM; Salgado N; Ferreira ASP; Costa APM
    J Bras Nefrol; 2017; 39(2):141-145. PubMed ID: 28489180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study.
    Fabrizi F; Tarantino A; Castelnovo C; Martin P; Messa P
    Kidney Blood Press Res; 2015; 40(6):584-92. PubMed ID: 26566033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines.
    Grzegorzewska AE
    Expert Rev Vaccines; 2014 Nov; 13(11):1317-26. PubMed ID: 25148051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
    Janssen RS; Mangoo-Karim R; Pergola PE; Girndt M; Namini H; Rahman S; Bennett SR; Heyward WL; Martin JT
    Vaccine; 2013 Nov; 31(46):5306-13. PubMed ID: 23727422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysis.
    Liu J; Wu H; Chen H
    Hepatol Res; 2018 Feb; 48(2):119-126. PubMed ID: 29197147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis.
    Li ZK; Nie JJ; Li J; Zhuang H
    Vaccine; 2013 Sep; 31(40):4355-61. PubMed ID: 23887040
    [TBL] [Abstract][Full Text] [Related]  

  • 28.  Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):21-47. PubMed ID: 28051791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus vaccine and chronic kidney disease. The advances.
    Fabrizi F; Cerutti R; Dixit V; Ridruejo E
    Nefrologia (Engl Ed); 2021; 41(2):115-122. PubMed ID: 33423842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus.
    Janssen JM; Heyward WL; Martin JT; Janssen RS
    Vaccine; 2015 Feb; 33(7):833-7. PubMed ID: 25576215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccine response in obesity: A meta-analysis.
    Fan W; Chen XF; Shen C; Guo ZR; Dong C
    Vaccine; 2016 Sep; 34(40):4835-41. PubMed ID: 27546877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
    Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy.
    Chlabicz S; Grzeszczuk A; Łapiński TW
    Med Sci Monit; 2002 May; 8(5):CR379-83. PubMed ID: 12011781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.
    Van Der Meeren O; Crasta P; Cheuvart B; De Ridder M
    Hum Vaccin Immunother; 2015; 11(7):1726-9. PubMed ID: 25996260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus infection and related factors in hemodialysis patients in China - systematic review and meta-analysis.
    Wang C; Sun J; Zhu B; Larsen S; Yu R; Wu J; Zhao W
    Ren Fail; 2010; 32(10):1255-64. PubMed ID: 20954991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis.
    Kamath GR; Shah DP; Hwang LY
    Vaccine; 2014 Apr; 32(20):2265-74. PubMed ID: 24631093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.